In this report, the EMEA Oral Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Oral Vaccines for these regions, from 2012 to 2022 (forecast)
- Europe: Germany, France, UK, Russia, Italy and Benelux;
- Middle East: Saudi Arabia, Israel, UAE and Iran;
- Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Oral Vaccines market competition by top manufacturers/players, with Oral Vaccines sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
- GlaxoSmithKline Plc.
- PaxVax Corporation
- Merial, Inc.
- Merck Sharp & Dohme Corp
- VALNEVA Canada Inc.
- QU�MICA SUIZA S.A
- Immunitor, Inc
- Aventis (Sanofi S.A.)
- Serum Institute of India Pvt. Ltd
- Swiss Serum and Vaccine Institute Berne
- Bull Bio – NCIPD Ltd.
- Vaxart, Inc.
- Shantha Biotechnics
- Crucell (Janssen Global Services, LLC)
Request Sample Copy @ https://www.reportsmonitor.com/request-sample/?post=102880
On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
- Live Attenuated Vaccines
- Killed/Inactivated Vaccines
- Recombinant Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Oral Vaccines for each application, including
- Respiratory Infections
To Browse Complete Report visit @ https://www.reportsmonitor.com/emea-europe-middle-east-and-africa-oral-vaccines-market-report-2017/
Table of Contents
EMEA (Europe, Middle East and Africa) Oral Vaccines Market Report 2017
1 Oral Vaccines Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Classification of Oral Vaccines
1.2.1 EMEA Oral Vaccines Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Oral Vaccines Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Live Attenuated Vaccines
1.2.4 Killed/Inactivated Vaccines
1.2.5 Recombinant Vaccines
1.3 EMEA Oral Vaccines Market by Application/End Users
1.3.1 EMEA Oral Vaccines Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.7 Respiratory Infections
1.4 EMEA Oral Vaccines Market by Region
1.4.1 EMEA Oral Vaccines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oral Vaccines (2012-2022)
1.5.1 EMEA Oral Vaccines Sales and Growth Rate (2012-2022)
1.5.2 EMEA Oral Vaccines Revenue and Growth Rate (2012-2022)
Direct: +1 513 549-5911
Google plus :https://plus.google.com/u/0/104187516885663390925